Cambium Bio Limited (ASX:CMB)
0.4050
0.00 (0.00%)
Jul 14, 2026, 2:49 PM AEST
Cambium Bio Revenue
Cambium Bio had revenue of 544.09K AUD in the half year ending December 31, 2025, with 54,409,100.00% growth. This brings the company's revenue in the last twelve months to 668.79K, down -19.15% year-over-year. In the fiscal year ending June 30, 2025, Cambium Bio had annual revenue of 774.88K with 337.80% growth.
Revenue (ttm)
668.79K
Revenue Growth
-19.15%
P/S Ratio
16.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 774.88K | 597.89K | 337.80% |
| Jun 30, 2024 | 177.00K | -837.20K | -82.55% |
| Jun 30, 2023 | 1.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition